Skip to content

Comparison of Noninvasive vs. Invasive Hemodynamic Measurements

Comparison Study of ezCVP and CVP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06689215
Enrollment
30
Registered
2024-11-14
Start date
2024-10-21
Completion date
2027-03-30
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Congestive

Brief summary

Comparison of a non-invasive method of measuring central venous pressure to the conventional modality of invasive central venous pressure.

Detailed description

The conventional method used to measure central venous pressure has limitations since it is an invasive procedure that requires a central venous catheter. To overcome this challenge, a new technology to assess CVP non-invasively using an oscillometric method is being developed. It is called enclosed zone central venous pressure (ezCVP). A comparison study of ezCVP and CVP is needed to determine accuracy and reproducibility.

Interventions

Non-invasive method to measure central venous pressure indicator

Sponsors

Nihon Kohden
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult age over 18 years. 2. Arm circumference is 18 cm to 55 cm 3. Subject will have an existing indwelling central venous catheter during their ICU stay 4. Subject or legally authorized representative (LAR) is able to understand the risks and potential benefits of participating in the study and is willing to provide written informed consent 5. Subject or LAR is willing and able to comply with protocol procedures

Exclusion criteria

1. Finger and/or upper arm anatomical anomaly or disease that may interfere with attaching a pulse oximeter sensor and/or blood pressure cuff. 2. Pregnant (self-reported) 3. Upper extremity deep venous thrombosis currently being treated 4. Severe skin disease involving the upper arm(s) 5. Study investigator may exclude patients based on clinical judgement

Design outcomes

Primary

MeasureTime frameDescription
Non-invasive pressure indicator1-7 daysEvaluate sensitivity and specificity of ezCVP indication based on the case where CVP is in a 'low range' (0 \< CVP \< 10 mmHg) or 'high range' (\>= 10 mmHg)

Secondary

MeasureTime frameDescription
Direction of change1-7 daysCorrelate the directionality of ezCVP change to invasive CVP change over time (i.e., increasing, decreasing or remaining stable).
Correlation with invasive CVP1-7 daysQuantify the agreement between ezCVP (non-invasive) and CVP (invasive)

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMasataka Kawana, MD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026